Neuronetics, Inc. (STIM) Debt Components
- 2026-06-30: Short-term DebtUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $61.52M; Long-term DebtUSD $61.52M; Long-Term Debt, Maturity, Year FourUSD (m).
- 2026-03-31: Short-term DebtUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $61.30M; Long-term DebtUSD $61.30M; Long-Term Debt, Maturity, Year FourUSD (m).
- 2025-12-31: Short-term DebtUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $65.81M; Long-term DebtUSD $65.81M; Long-Term Debt, Maturity, Year FourUSD (m).
- 2025-12-31: Short-term DebtUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year FourUSD $70.00M.
Neuronetics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-term Debt, Gross USD | Debt Instrument, Face Amount USD | Debt, Long-term and Short-term, Combined Amount USD | Debt Instrument, Basis Spread on Variable Rate pure | Debt Instrument, Unamortized Discount USD | Long-term Debt, Current Maturities USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $61.52M | $61.52M | (m) | (m) | $65.00M | (m) | (m) | (m) | $3.48M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $61.30M | $61.30M | (m) | (m) | $65.00M | (m) | (m) | (m) | $3.70M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $65.81M | $65.81M | (m) | (m) | $70.00M | (m) | (m) | (m) | $4.19M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | (m) | $70.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $65.67M | $65.67M | (m) | (m) | $70.00M | (m) | (m) | (m) | $4.33M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $55.54M | $55.54M | (m) | (m) | $60.00M | (m) | (m) | (m) | $4.46M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $55.34M | $55.34M | (m) | (m) | $60.00M | (m) | (m) | (m) | $4.66M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $55.15M | $55.15M | (m) | (m) | $60.00M | (m) | (m) | (m) | $4.85M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | $60.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-11-06 | (m) | (m) | (m) | (m) | (m) | (m) | $5.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-10-15 | (m) | (m) | (m) | (m) | (m) | (m) | $5.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-10-03 | (m) | (m) | (m) | (m) | (m) | (m) | $5.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 7.65% | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $11.42M | (m) | (m) | (m) | (m) | $131.77M | (m) | $146.25M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $46.00M | $46.00M | (m) | (m) | (m) | (m) | (m) | (m) | $4.00M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | $60.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $46.15M | $59.76M | (m) | (m) | (m) | (m) | (m) | (m) | $3.21M | $13.61M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $59.44M | $59.44M | (m) | (m) | $60.00M | (m) | (m) | (m) | $2.41M | (m) | (m) | (m) | (m) |
| 2024-02-29 | (m) | (m) | (m) | (m) | (m) | $60.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-01-31 | (m) | (m) | (m) | (m) | (m) | $60.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $59.28M | $59.28M | (m) | (m) | $60.00M | (m) | (m) | (m) | $2.57M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $30.00M | $7.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $22.50M |
| 2023-10-13 | (m) | (m) | (m) | (m) | (m) | (m) | $6.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $36.85M | $36.85M | (m) | (m) | $37.50M | (m) | (m) | (m) | $2.50M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $36.71M | $36.71M | (m) | (m) | $37.50M | (m) | (m) | (m) | $2.64M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $36.64M | $36.64M | (m) | (m) | $37.50M | (m) | (m) | (m) | $2.71M | (m) | (m) | (m) | (m) |
| 2023-02-03 | (m) | (m) | (m) | (m) | (m) | (m) | $750.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $22.83M | $35.95M | (m) | (m) | $35.00M | (m) | (m) | (m) | $971.00K | $13.12M | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.12M | $17.50M | $4.38M |
| 2022-09-30 | (m) | $27.01M | $35.76M | (m) | (m) | $35.00M | (m) | (m) | (m) | $1.17M | $8.75M | (m) | (m) | (m) |
| 2022-06-30 | (m) | $31.21M | $35.59M | (m) | (m) | $35.00M | (m) | (m) | (m) | $1.34M | $4.38M | (m) | (m) | (m) |
| 2022-03-31 | (m) | $35.44M | $35.44M | (m) | (m) | $35.00M | (m) | (m) | (m) | $1.48M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $35.34M | $35.34M | (m) | (m) | $35.00M | (m) | (m) | (m) | $1.59M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | $35.10M | (m) | (m) | $35.00M | (m) | (m) | (m) | $1.82M | $35.10M | (m) | (m) | (m) |
| 2021-06-30 | (m) | $34.94M | $34.94M | (m) | (m) | $35.00M | (m) | (m) | (m) | $1.98M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $34.79M | $34.79M | (m) | (m) | $35.00M | (m) | (m) | (m) | $2.13M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $34.62M | $34.62M | (m) | (m) | $35.00M | (m) | (m) | (m) | $2.31M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $34.54M | (m) | (m) | $35.00M | (m) | (m) | (m) | $2.38M | $34.54M | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $34.37M | (m) | (m) | $35.00M | (m) | (m) | (m) | $2.55M | $34.37M | (m) | (m) | (m) |
| 2020-03-31 | (m) | $34.21M | $34.21M | (m) | (m) | $35.00M | (m) | (m) | (m) | $2.71M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $19.90M | $31.15M | (m) | (m) | $30.00M | (m) | (m) | (m) | $690.00K | $11.25M | (m) | (m) | (m) |
| 2019-09-30 | (m) | $23.45M | $30.95M | (m) | (m) | $30.00M | (m) | (m) | (m) | $790.00K | $7.50M | (m) | (m) | (m) |
| 2019-06-30 | (m) | $27.01M | $30.76M | (m) | (m) | $30.00M | (m) | (m) | (m) | $889.00K | $3.75M | (m) | (m) | (m) |
| 2019-03-31 | (m) | $30.57M | (m) | (m) | (m) | $30.00M | (m) | (m) | (m) | $983.00K | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $30.39M | $30.39M | (m) | (m) | $30.00M | (m) | (m) | (m) | $1.07M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $25.20M | $30.20M | (m) | (m) | $30.00M | (m) | (m) | (m) | $1.18M | $5.00M | (m) | (m) | (m) |
| 2018-06-30 | (m) | $27.50M | $30.00M | (m) | (m) | $30.00M | (m) | (m) | (m) | $1.29M | $2.50M | (m) | (m) | (m) |
| 2017-12-31 | (m) | $29.56M | $29.56M | (m) | (m) | $30.00M | (m) | (m) | (m) | $1.38M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |